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Abstract
Background: Lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18, alphaLbeta2), the
most abundant and widely expressed beta2-integrin, is required for many cellular adhesive
interactions during the immune response. Many studies have shown that LFA-1 is centrally involved
in the pathogenesis of several diseases caused by Repeats-in-toxin (RTX) -producing bacteria.
Results: The porcine-LFA-1 CD11a (alpha) subunit coding sequence was cloned, sequenced and
compared with the available mammalian homologues in this study. Despite some focal differences,
it shares all the main characteristics of these latter. Interestingly, as in sheep and humans, an allelic
variant with a triplet insertion resulting in an additional Gln-744 was consistently identified, which
suggests an allelic polymorphism that might be biologically relevant.
Conclusion: Together with the pig CD18-encoding cDNA, which has been available for a long
time, the sequence data provided here will allow the successful expression of porcine CD11a, thus
giving the first opportunity to express the Sus scrofa beta2-integrin LFA-1 in vitro as a tool to
examine the specificities of inflammation in the porcine species.
Background
Integrins constitute a large family of adhesion molecules
with important roles in cell-extracellular matrix and cell-
cell interactions which condition both the maintenance of
tissue integrity and the promotion of cellular migration.
They are heterodimeric membrane glycoproteins com-
posed of non-covalently associated single-pass transmem-
brane α and β subunits, which are expressed on a wide
range of cells [1]. The biggest part of each integrin subunit
is extracellular while transmembrane region and cytoplas-
mic tail are typically reduced. The N-terminal domains of
the α and β subunits associate to form the integrin head-
piece, which contains the ligand binding site. The C-ter-
minal segments traverse the plasma membrane and
mediate interactions with the cytoskeleton and with sig-
nalling proteins [2,3].
Among the integrins, the leukocyte-specific β2-integrins
(CD11/CD18) include four members: (i) CD11a/CD18
(LFA-1, αLβ2) on all leukocytes ; (ii) CD11b/CD18 (Mac-
1, CR3, αMβ2) mainly on myeloid cells ; (iii) CD11c/
CD18 (gp150/95, CR4, αXβ2, Leu-M5) and (iv) CD11d/
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CD18 (αDβ2) on monocytes and macrophages [4]. The
individuals lacking functional β2 integrins due to muta-
tions in the β2 (CD18) subunit develop the LAD (lym-
phocyte adhesion deficiency) I syndrome characterized by
repeated infections. This disease demonstrated that β2
integrins are of relevant importance in (i) leukocyte devel-
opment and maturation, (ii) naïve cells circulation in sec-
ondary lymphoid tissues and (iii) leukocytes
transendothelial migration to injured tissue [5-7].
Lymphocyte function-associated antigen-1 (LFA-1,
CD11a/CD18, αLβ2), the most abundant and widespread
in expression β2-integrin, binds to the membrane proteins
termed intercellular adhesion molecules ICAM-1 to
ICAM-5 [4,8-12]. Several studies have shown that LFA-1 is
centrally involved in the pathogenesis of diseases caused
by Repeats-in-toxin (RTX) -producing bacteria. The viru-
lence of both Actinobacillus actinomycetemcomitans (stoma-
titis in humans) and Mannheimia haemolytica (pneumonia
in cattle) is clearly associated with the ligand-receptor
interactions between their respective leukotoxin and
CD11a/CD18, which triggers the synthesis and release of
a wide array of cytokines and chemoattractants that exac-
erbate inflammation, and ultimately results in massive
leukolysis [13,14]. As Actinobacillus pleuropneumoniae, the
main causative agent of pneumonia in pigs, also produces
toxins of the RTX family (Apx toxins) [15], it is tempting
to hypothesize that the pathogenesis of the disease simi-
larly rely on an interaction with the porcine LFA-1. On a
more practical point of view, increasing our knowledge
about this putative interaction could help the pig industry
in controlling the economical losses and antibiotics
abuses that are currently associated with A. pleuropneumo-
niae pneumonia [16]. The Sus scrofa CD18 (β2-) subunit
has been well characterized [17], which is not the case of
its partner in the LFA-1 heterodimer, CD11a. The purpose
of this study is to report the cloning, sequencing and anal-
ysis of a cDNA encoding porcine CD11a, thus giving the
first opportunity to produce recombinant LFA-1 for stud-
ies focused on interactions between Apx toxins and swine
LFA-1.
Results and discussion
Characterization of PoCD11a-encoding cDNA and 
deduced amino-acid sequence
The PoCD11a cDNA sequence contains an ORF of 3519
bp [GenBank:DQ013285] or 3522 bp [Gen-
Bank:DQ013284] that codes for 1172 or 1173 aa fol-
lowed by ~500 bp that constitute the 3'-UTR (Fig. 1). The
1173 aa mature PoCD11a contains a 23-residue putative
leader peptide (residues 1–23), an extracellular domain of
1064 residues (24–1087), a single hydrophobic trans-
membrane region of 24 residues (1088–1111) and a short
cytoplasmic tail of 62 residues (1112–1173) (Fig. 1). Six
N-linked putative glycosylation sites (Asn-Xaa-Ser/Thr)
are found in the extracellular domain (Fig. 1). The
PoCD11a possesses 22 cysteine residues, among which
one is located into the cytoplasmic tail (Fig. 1). A subset
of integrin α chains (α1, α2, α10, α11, αD, αE, αL, αM and
αX), including CD11a, contain an I-domain (for Inserted
domain and also called αLI-domain or  LA-domain) that
is homologous to the family of von Willebrand Factor
(vWF) A-type domains and to cartilage matrix protein
[1,18]. The I-domain has been associated with ligand
binding. Its three-dimensional structure consists of a five-
stranded parallel β-sheet core surrounded on both faces
by seven α-helices. A short antiparallel strand occurs on
one edge of this sheet [19]. The I-domain (148–331) con-
tains a metal ion-dependent adhesion site (MIDAS) (resi-
dues 160–164, 229, 262) [19] (Fig. 1). The I-domain
crystallisation has demonstrated that a "closed" (low
affinity) and an "open" (high affinity) forms exist, and
that the major conformational changes during transition
from the closed to open states include a rearrangement of
the cation-coordinating residues in the MIDAS site,
accompanied by a small inward movement of the α1 helix
and a large downward shift of the mobile C-terminal α7
helix [20]. The extracellular domain of PoCD11a contains
seven internal repeats that surround the I-domain [21].
The degree of identity is highest among the three COOH-
terminal repeats (18–31%) and their central region (466–
474, 528–536 and 588–596) is similar to the EF hand
divalent cation-binding motifs of troponin C, parvalbu-
min and galactose binding protein [21] (Fig. 1). All the N-
glycosylation sites and all but one cysteine residues are
found outside the I-region and divalent cation binding
motifs (Fig. 1), consistent with the hypothesis that these
regions may undergo conformational changes important
in ligand binding [21,22]. The cytoplasmic portion of
PoCD11a contains three potential phosphorylation sites
and also a conserved "GFFKR" basic sequence near the
transmembrane region (Fig. 1). The integrins become
constitutively active when this sequence is deleted, the
GFFKR motif thus normally fixes the integrins in an inac-
tive state [4,23].
Among the seven positive clones sequenced, two pre-
sented a supplementary "cag" codon (2230–2232) that
codes for a glutamine (Gln, Q) in position 744 [Gen-
Bank:DQ013284]. This addition is located in the extracel-
lular domain of PoCD11a, outside of the I-domain and
divalent cation-binding motifs and, according to the
GORIV bioinformatic program, increased the length of an
α-helix. The Gln-744 addition was also observed in the
human [GenBank:NM_002209, GenBank:AY892236]
and ovine [24] CD11a cDNAs. The Gln addition could
thus have a biological importance for the mature CD11a.
Studies of genomic sequences will permit to know if this
α .BMC Veterinary Research 2005, 1:5 http://www.biomedcentral.com/1746-6148/1/5
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addition represents two alleles or if it is generated by an
alternative splicing.
Comparison among species
Overall, the general organization of porcine, human [21],
murine [25], bovine [26] and ovine [24] CD11a proteins
is quite similar (Fig. 2). Comparison between mature
PoCD11a sequence and its human, murine, bovine and
ovine counterparts shows overall 77%, 69%, 78% and
77% identity, respectively, with the highest identity for
the MIDAS, the cation binding motifs and the transmem-
brane region and the lowest identity for the cytoplasmic
tail (Table 1). The high conservation of the MIDAS and
the putative cation binding motifs is consistent with an
involvement of these regions in the functional activity of
LFA-1 α subunit, as suggested by the requirement of Mg2+
and Ca2+  for CD11a/CD18-dependent cellular interac-
tions [22] or binding to purified ICAM-1 [27,28]. The
transmembrane region shows also a high degree of con-
servation that could be explained by (i) physicochemical,
The nucleotide and deduced amino acid sequences of Sus scrofa CD11a cDNA Figure 1
The nucleotide and deduced amino acid sequences of Sus scrofa CD11a cDNA. The putative leader peptide and 
transmembrane region are respectively represented by green and dark blue boxes. The αI-domain is showed by a yellow box. 
Its five-stranded β-sheets and seven α-helices are underlined. Its metal-ion dependent adhesion site (MIDAS) is represented by 
red boxes. The sequences of the seven repeats that surround the αI-domain are framed. Light blue boxes represent the central 
divalent cation-binding motifs (DCBM) of the three COOH-terminal repeats. The important Glu-333 residue (E) and the sup-
plementary Gln-744 (Q) are in black boxes. The conserved sequence "GFFKR" of the cytoplasmic tail, near the transmembrane 
region, is in a dark grey box. Cysteine residues (¤), potential N-glycosylation sites (#) and potential cytoplasmic-tail phosphor-
ylation sites (+) are marked at the top of the sequences. Seven independent clones were sequenced in both directions. 
Sequence data have been deposited at GenBank under accession nos. DQ013285 and DQ013284 (shown here). Both 
sequences differ by a glutamine deletion in position 744 in sequence DQ013284.BMC Veterinary Research 2005, 1:5 http://www.biomedcentral.com/1746-6148/1/5
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and (ii) functional constraints. Indeed, (i) residues lying
in the membrane have to possess a hydrophobic character
to warrant liposolubility, which is confirmed by the pres-
ence of many leucine residues (fig. 2) and (ii) bi-direc-
tional integrin signalling (inside-out and outside-in) is
accomplished by transmission of information across the
plasma membrane [29]. By contrast, the low conservation
of the COOH-terminal part of the cytoplasmic tail sug-
gests that it is not required to guarantee adequate func-
tioning of LFA-1. This is in agreement with the
observation that truncation of the LFA-1 α subunit cyto-
plasmic domain has no effect on binding to ICAM-1,
whereas binding is markedly diminished by β subunit
cytoplasmic domain truncation [30]. However, the part
near the transmembrane region of the cytoplasmic tail,
containing the "GFFKR" sequence, is highly conserved
(Table 1). This is consistent with the stabilizing role of this
motif for the alpha/beta complex, possibly because of its
direct involvement in heterodimer formation [23]. Resi-
due Glu-333 that is located in the linker following the I
domain and that is known to be critical for communica-
tion to the β2 I-like domain, rolling, integrin extension
and activation by Mn2+ of firm adhesion [31] is strictly
conserved, too (fig. 2).
Every cysteine residue in the mature porcine CD11a is
present at the same location in human, murine, bovine
and ovine CD11a, which is consistent with a role in main-
taining the global structure of the protein. The mouse ver-
sion distinguishes by an additional cysteine residue at
position 199 within the extracellular portion. Of six
potential Asn-glycosylation sites in porcine CD11a, the
ones present at amino acids 186, 668, 724 and 860 are
strictly conserved. Without predictable consequences on a
functional point of view, one glycosylation site is only
absent from porcine and murine CD11a (residue 897 of
human sequence). The mouse sequence shows additional
glycosylation sites at position 270 and 776. Furthermore,
the porcine Asn-Xaa-Ser/Thr sites in position 87 and 728
are also found in human and murine homologues but not
specially in the ruminant sequences, and the ovine
sequence owns two supplementary sites at position 646
and 1000.
Conclusion
This study reports for the first time the isolation and
sequencing of the porcine LFA-1 αL  subunit (CD11a)
cDNA, and demonstrates that, despite some focal differ-
ences, it shares all the main characteristics of its known
mammalian homologues. Along with the porcine CD18-
encoding cDNA which is available [17], the sequence data
provided here allow the successful cloning of PoCD11a,
thus giving the first opportunity to express porcine LFA-1
in vitro as a tool to examine the specificities of inflamma-
tion in the porcine species.
Methods
RNA isolation
Total RNA from spleen of a freshly slaughtered pig (Sus
scrofa domestica) was extracted with TRIzol (Invitrogen,
USA) as described by the manufacturer.
Amplification of cDNA ends
We used SMART RACE technology (Clontech Laboratories
Inc., USA) to obtain porcine CD11a (PoCD11a) 5'- and
3'- ends and RT-PCR to amplify full-length PoCD11a
CDS. For first strand cDNA synthesis, and according to the
bovine CD11a sequence available [GenBank:AY267467],
gene-specific primers were designed which were expected
to give nonoverlapping ~1,5 kb rapid amplification of
cDNA ends (RACE) products : a sense primer for the 3'-
RACE PCR 5'-tgcaatgtragctctcccatcttc-3' (corresponding to
nt 2575–2598) and an antisense primer for the 5'-RACE
PCR 5'-aagatgtacacrgccccctgctcctcca-3' (nt 1628–1655).
Reverse transcription and polymerase chain reactions
(PCR) were carried out according to the instruction man-
Table 1: Between-species percent identities of CD11a constitutive blocks. Po, Hu, Mu, Bo and Ov : porcine, human, murine, bovine and 
ovine CD11a, respectively ; MIDAS: metal-ion dependent adhesion site ; vs : versus.
Block Po vs. Hu (%) Po vs. Mu (%) Po vs. Bo (%) Po vs.Ov (%)
Overall 77 69 78 77
Putative signal peptide 56 45 86 78
Extracellular domain 77 70 77 78
I-domain 79 72 82 82
M I D A S 8 58 58 58 5
Putative cation binding motif 1 77 77 66 66
Putative cation binding motif 2 77 77 77 77
Putative cation binding motif 3 88 88 100 100
Transmembrane region 91 75 83 87
Cytoplasmic tail 55 47 55 53
"GFFKR" motif 100 100 100 100BMC Veterinary Research 2005, 1:5 http://www.biomedcentral.com/1746-6148/1/5
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Comparison of the porcine (Po-), human (Hu-), murine (Mu-), bovine (Bo-) and ovine (Ov-) α subunits amino acids sequences Figure 2
Comparison of the porcine (Po-), human (Hu-), murine (Mu-), bovine (Bo-) and ovine (Ov-) α subunits amino 
acids sequences. Black column with white letter, dark gray column with white letter and light gray column with black letter 
represent identity among 5, 4 and 3 species, respectively. Cysteine residues (¤), potential N-glycosylation sites (#) and poten-
tial cytoplasmic-tail phosphorylation sites (+) are marked at the bottom of the sequences. The important Glu-333 residue (E) 
and the Gln-744 residue (Q) are respectively identified by ($) and (=). The stripes above the sequences represent the deduced 
different constitutive parts of the protein: signal peptide ( ), extracellular domain ( ), transmembrane region 
( ), cytoplasmic tail ( ),αI-domain ( ) and its metal-ion dependent adhesion site ( ), and the central 
divalent cation-binding motifs of the three COOH-terminal repeats ( ). The highly conserved "GFFKR" motif of the cyto-
plasmic tail is framed for the different species.
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ual of the SMART RACE cDNA Amplification Kit. The 5'-
and 3'-RACE products were gel-purified using the
Qiaquick Gel Extraction Kit (Qiagen), TA-cloned into
pCRII-TOPO (Invitrogen, USA) and seeded on kanamycin
IPTG plates. Minipreps were obtained from colonies
grown in 5 ml LB-Kan broth and the clones were
sequenced on the ABI-3100 Genetic Analyzer using the
Big Dye terminator chemistry (Applied Biosystems, USA).
Molecular cloning of full-length cDNA
Total RNA from spleen cells was reverse transcribed using
Improm II (Promega, USA). The full-length cDNA was
then generated by long distance PCR using elongase
amplification technology (Invitrogen, USA) with primers
designed from the proximal part of 5'- and the distal part
of 3'-RACE products: 5'-ggtatggtccctccagaagc-3' (forward)
and 5'-tcaggcctgggcttcagtcg-3' (reverse). The following
cycling parameters were applied: 5 min at 94°C, then 35
cycles including: (i) 30 s at 94°C, (ii) 45 s at 58°C, and
(iii) 3 min 30 s at 68°C, followed by a final extension at
68°C for 10 min. Resulting PCR products were then proc-
essed for sequencing as aforementioned for the RACE
products. The CD11a cDNA sequence was deduced from
sequences obtained from seven independent clones.
Sequence data have been deposited at GenBank under
accession nos. DQ013285 and DQ013284.
Bioinformatics
Primers design was performed with Netprimer [32] and
Primer 3 [33]. Nucleotidic sequence and identity analyses
were carried out using respectively Chromas v.2.21 [34]
and BLAST programs [35]. Alignment of amino acids
sequences was drawn by GeneDoc v.2.6.002 [36] follow-
ing the blosum 62 matrix. SignalP v.2.0.b2 [37] and
NetNGlyc v.1.0 [38] provided peptide signal and N-glyco-
sylation sites prediction, respectively. The secondary struc-
tures were resolved by the GOR secondary structure
prediction method version IV [39].
List of abbreviations
aa, amino acid ; Bo, bovine; CD, cluster of differenciation
; CR, complement receptor ; DCBM, divalent-cation bind-
ing motif ; Hu, human; ICAM, intercellular adhesion mol-
ecule; kan, kanamycin ; LFA, lymphocyte function-
associated antigen; MIDAS, metal-ion dependent adhe-
sion site; Mu, murine; Ov, ovine ; Po, porcine ; RACE,
rapid amplification of cDNA ends ; TCR, T-cell receptor.
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